
Sign up to save your podcasts
Or


Dr. Manfred Franke comes on again to explain some of the pros and cons to different educational approaches. We then talk about what we couldn't talk about last time: the approval of his neurostimulator device through the FDA. This device naturally stimulates a tear response in the eyes instead of adding artificial solutions. The device was approved by the FDA in about 4 years which suggests that the future of neurostimulators may be more nimble than pharmaceuticals.
By Ladan Jiracek4.8
1717 ratings
Dr. Manfred Franke comes on again to explain some of the pros and cons to different educational approaches. We then talk about what we couldn't talk about last time: the approval of his neurostimulator device through the FDA. This device naturally stimulates a tear response in the eyes instead of adding artificial solutions. The device was approved by the FDA in about 4 years which suggests that the future of neurostimulators may be more nimble than pharmaceuticals.

4,997 Listeners

4,164 Listeners

10,581 Listeners

136 Listeners

760 Listeners

532 Listeners

112,360 Listeners

15,333 Listeners

1,087 Listeners

29,220 Listeners

10,786 Listeners

28 Listeners